I mmigrants' mental health has important implications for health provision in their host countries. 1, 2 While a large influx of healthy newcomers can improve the mental health profile of the general population, 3, 4 distressed and mentally ill immigrants are likely to increase the burden on health care and social welfare services. 5, 6 However, there is growing evidence that challenges the common belief that mental illness is more frequent among immigrants than indigenous populations. [7] [8] [9] Schizophrenia, affective disorders, substance abuse, and posttraumatic stress disorder among immigrants have been areas of great research interest. 10, 11 However, the relation between immigration and stress-related anxiety disorders¯which account for most psychiatric cases in the community¯and the association between immigrant status, and affective and anxiety disorders have been studied far less. 12 The past 2 decades have witnessed a huge wave of Jewish emigration from the former Soviet Union to the West. The vast majority of immigrants who arrived in Israel between 1989 and 2004 (n = 1 180 870) were Jews from the former Soviet Union (n = 962 458). 13 Such a massive migration may change service needs and health patterns in host societies substantially and to manage such a change successfully, information about the mental health of incoming immigrants is crucial. The INHS is the first nationwide study designed to estimate the prevalence rates of common mental disorders and health service and psychotropic drug use in the adult population. Before the INHS, health care surveys in Israel were limited to population subgroups, to measures of nonspecific psychological distress, or to populations in care. [14] [15] [16] [17] [18] The INHS makes it possible to estimate and compare the need for mental health services and treatment in the immigrant and Israeli populations. The findings will better inform health providers and policy-makers at national, regional, and local levels and guide their decisions on the development of services and interventions both for immigrants and for Israelis. These data could also substantially supplement the epidemiologic picture for mental disorders, and health service and psychotropic drug use among immigrants in other countries across the world.
The general objective of our study was to estimate the prevalence of common mental disorders and the extent of health care and psychotropic drug use in the general population and in recent immigrants to Israel. Specifically, we aimed to compare immigrants who arrived in the country after 1989 with Israelis, that is, those born in Israel or those who emigrated to Israel before 1989, concerning their 12-month prevalence rate for mood and anxiety disorders; use of health care services; and psychotropic drug use.
Methods

Sampling, Procedures, and Subjects
The INHS, as a component of the 27-country World Mental Health Survey, followed established uniform procedures. 19 A detailed description of the Israeli sample and procedures is given elsewhere. 20 Briefly, the Israeli sample was extracted from Israel's National Population Register and was comprised of noninstitutionalized, de jure residents aged 21 years and older. The sample was designed to reflect the distribution of selected sex-age-population groups in the general population (Arab and Jewish Israelis, native-born Israelis, and immigrants from the former Soviet Union or elsewhere). The sample was weighted back to the total population to compensate for unequal selection probabilities owing to disproportionate stratification, clustering effects, and nonresponse. These weights were adjusted to make weighted sample totals conform to known population totals from reliable Central Bureau of Statistics sources. Face-to-face interviews at respondents' homes were conducted from May 2003 to April 2004, in Hebrew, Russian, or Arabic. The survey was administered using laptop computer-assisted personal interview methods by professional survey interviewers, trained and supervised by the Central Bureau of Statistics. The study was approved by the Israel Ministry of Health's Experimentation on Human Subjects Committee. Verbal informed consent was obtained from all respondents.
The overall response rate was 73%. Among the 4859 respondents who completed interviews, 845 were immigrants from the former Soviet Union and 107 were immigrants from other countries (both groups post-1989), and 3906 were Israelis. The latter consisted of 2758 native-born Israelis and 1148 immigrants who immigrated to Israel from elsewhere prior to 1989.
Diagnostic Assessment
The diagnostic instrument used in the INHS was the CIDI, 19 a structured diagnostic interview for assessing the lifetime and 12-month prevalence of selected psychiatric disorders on both the International Classification of Diseases, 10th Revision and the DSM-IV classification systems. We assessed the following disorders: anxiety disorders (panic disorder, generalized anxiety disorder, agoraphobia without panic disorder, and posttraumatic stress disorder) and mood disorders (major depressive disorder, dysthymia, and bipolar disorder I and II). Prevalence estimates for mental disorders were determined from the respondents' self-reporting of current symptoms that met the 12-month diagnostic criteria for DSM-IV disorder. At the same time as the CIDI interviews, health service and psychotropic drug use was assessed.
Assessment of the Use of Health Services
Respondents were asked about their use of all health services during the 12 months preceding the survey relating to their emotional or mental health problems. These services included: consulting any mental health professional (psychiatrist, psychologist, social worker, or other specialist mental health provider) in a public, private, workplace, or welfare setting; consulting nonpsychiatrist medical professionals (general practitioners, or other medical doctors or health professionals); and consulting informal health care providers, such as social workers, religious leaders, counsellors, or traditional healers. Questions probing service use were included in several sections of the CIDI¯in the section on general services and in each diagnostic section dealing with a specific psychiatric category. The data reported here are taken from the general section only, and for this reason service use may be slightly underestimated.
Assessment of Psychotropic Drug Use
All respondents were asked about the use of any psychotropic medication during the 12 months preceding the survey, even if used only once. Questions probing drug use were included in each diagnostic section dealing with a specific psychiatric disorder. In addition, a section comprising 191 items specifically inquired, in detail, into drug use, the prescribing clinician(s), the duration and frequency of use, reasons for discontinuation, and related issues. The analyses presented here refer to all episodes of use in the 12 months prior to the interview and do not distinguish between occasional use (a single episode over the year) and regular or systematic use. To overcome the recall bias that often hampers drug use studies (especially with respect to short-term use), a standard booklet was provided that listed the psychotropic drugs commonly used in Israel to treat mental health problems and psychiatric disorders. Psychotropic drugs were recorded in the interviews by their national brand names and then converted to a drug coding system based on the Anatomical Therapeutic Chemical classification system. 21 The data presented in this report are confined to 5 main drug categories: ADs (including tricyclics and new generation ADs); anxiolytics (including benzodiazepines and nonbenzodiazepine anxiolytic agents, such as buspirone); hypnotics of any pharmacological class; drugs used for the treatment of psychotic disorders, including antipsychotics (conventional and atypical antipsychotic agents, such as clozapine, olanzapine, quetiapine, ziprasidone, and risperidone) and antipsychotic depot injections; and mood stabilizers (including lithium, carbamazepine, valproate, gabapentin, topiramate, and lamotrigine). We expect that our estimate of mood stabilizer use is somewhat exaggerated as some of the drugs included are commonly used for other indications, for example, chronic pain treatment.
Statistical Analysis
The Rao-Scott chi-square test was used to compare sociodemographic characteristics. It is a design-adjusted version of the likelihood ratio test, which measures ratios between observed and expected frequencies and tests the null hypothesis of no association between row and column variables in a 2-way table. Prevalence estimates are computed and reported in absolute numbers and percentages, with 95% confidence intervals. We computed the proportion of respondents in the general population who reported using psychotropic drugs and health services in the 12 months preceding the interview. Cross-tabulations were used to calculate bivariate odds ratios and 95% confidence intervals to assess the intensity of reported drug and service use, and sex differences. Univariate logistic regression analysis was used to analyze the association of clinical-diagnostic characteristics with psychotropic drug and service use. All analyses were performed using the SAS 9.1 software package (SAS Institute Inc, Cary, NC), which is designed to analyze complex sample surveys and weighted data. Table 1 compares the sociodemographic characteristics of the total sample and its 3 subgroups: immigrants from the former Soviet Union, other immigrants, and Israelis. The overall mean age was 47.0 years (95% CI 46.7 to 47.4), with the largest group of respondents aged between 21 and 29 years (23%). Men made up 48% of the sample, nearly 68% of the sample were married, and 44% lived in urban areas. Almost one-half (47%) had higher education and most were in paid employment at the time of the interview (56%). Nearly 82% of the sample identified themselves as Jewish and the remainder as belonging to non-Jewish faiths; 17.4% of respondents were recent (post-1989) immigrants from the former Soviet Union, and 2.2% had immigrated from elsewhere.
Results
Sociodemographic Characteristics
Chi-square statistics showed that the immigrant subgroups were similar to one another but that both significantly differed from Israelis on most variables (all P < 0.001). Specifically, the immigrants were mostly women, older, higher educated, secular, and had more previously married people than the Israelis. The only exception was employment status, where no between-group differences were found. Given the similar sociodemographic profiles and the insignificant differences in time since immigration between the immigrants from the former Soviet Union and elsewhere (mean 9.3, SD 0.1, compared with mean 8.6, SD 0.4, respectively; t = 1.69, df = 908, P = 0.09), the 2 groups were pooled for further analyses. Table 2 compares the 12-month prevalence estimates for common mental disorders for immigrants and Israelis by sex. About each 10th respondent (9.7%) reported signs and symptoms during the past 12 months that met the DSM-IV criteria for a mood or anxiety disorder. There were no significant differences between immigrant and Israeli respondents for the estimates for any mental disorder (OR 0.9; 95% CI 0.7 to 1.1), for any mood disorder (OR 0.9; 95% CI 0.6 to 1.2), or for any anxiety disorder (OR 1.2; 95% CI 0.8 to 1.9). Likewise, there were no significant between-group differences in pure major depression (OR 0.8; 95% CI 0.6 to 1.1), pure mood disorder (OR 3.7; 95% CI 0.9 to 16.2), and pure anxiety disorder (OR 1.3; 95% CI 0.7 to 2.4). The only significant sex difference was found in the immigrant group, where women reported anxiety disorder more frequently than the men (OR 4.6; 95% CI 1.7 to 12.4). Table 3 shows the number of reported applications to professionals about mental health problems in the past 12 months, by immigrant status and sex. As with the disorder prevalence estimates, there were no significant differences in the use of either formal or informal health services between immigrant and Israelis diagnosed with a mental disorder in the previous 12 months (28.4%, compared with 35.6%; OR 1.4; 95% CI 0.9 to 2.3). Both in immigrants and in Israelis, significantly more frequent service use was found in women in the overall sample and in respondents with no recognizable disorder. Service use by Israeli women diagnosed with pure mood disorder was particularly frequent (OR 6.4; 95% CI 1.5 to 26.7). Table 4 presents the 12-month psychotropic drug use for 5 classes of drugs (ADs, anxiolytics, antipsychotics, mood stabilizers, and hypnotics) and for exclusive and combined drug use, by sex and immigrant status. In the 12 months prior to the study, Israelis took psychotropic medication (any class) significantly less often than immigrants did (OR 0.5; 95% CI 0.4 to 0.7). This was also the case for both overall use and the exclusive use of anxiolytics (OR 0.5; 95% CI 0.4 to 0.7), mood stabilizers (OR 0.4; 95% CI 0.3 to 0.6), and hypnotics (OR 0.5; 95% CI 0.3 to 0.7). Among Israelis and immigrants, women were significantly more likely than men to have used psychotropic drugs (any class) and anxiolytics; the sex differences were particularly marked in the immigrant group. significant sex differences in drug use among respondents who had been diagnosed with a mental disorder. Likewise, there were no significant differences in psychotropic drug use between Israelis and immigrants who had been diagnosed with any specific mental disorder. However, Israelis without a diagnosis were half as likely to take a psychotropic drug as their immigrant counterparts (OR 0.5; 95% CI 0.4 to 0.6).
Common Mental Disorders
Health Services Use
Psychotropic Drug Use
Discussion
The results show that, during the 12 months preceding the INHS, immigrants and Israelis were equally likely to have a common mental disorder, and to use both formal and informal health care services. However, compared with their Israeli counterparts, immigrants who did not meet the DSM-IV criteria for mental disorders were more likely to use psychotropic drugs, such as anxiolytics, mood stabilizers, and hypnotics. These findings substantially supplement the epidemiologic picture of mental disorders, health service, and psychotropic drug use among immigrants in European countries and across the world. [1] [2] [3] [4] [5] [22] [23] [24] [25] [26] [27] [28] [29] 
The Prevalence of Common Mental Disorders
The INHS found that about each 10th respondent had been diagnosed with a common mental disorder during the past year 30¯v ery similar to the rate reported in Europe. However, the frequencies for anxiety disorders and mood disorders were, respectively, somewhat higher and somewhat lower than in Europe. 31 This study found no significant differences in the rates of mental problems among immigrants, compared with the general population. This finding is inconsistent with community health survey results in other countries with a relatively large influx of immigrants [22] [23] [24] [25] [26] [27] [28] [29] : these surveys reported that immigrants suffered from mental health problems either more or less than the host population. Our results could be explained by the convergence hypothesis, which posits that, compared with the host population, immigrants may have a lower or higher mental health risk before or immediately after their arrival, but that their risk level converges with the general population level the longer the immigrants live in the new country. 27 The results may also be explainable by the characteristics of Israel's immigrant population, which could be associated with diagnostic bias, namely, the systematic under-diagnosing of mental disorders. However, the differences in the immigrants' and Israelis' sociodemographic profiles, with the immigrants having a higher proportion of women and unmarried people, and being older, more educated, and less religious than the general Israeli population, 32 make such an explanation unlikely, as the above characteristics have been consistently shown to be associated with higher rates of psychological distress and morbidity. 16 
Health Service Use
About 1 in 10 respondents had consulted either formal or informal health services during the 12 months prior to the survey (the same rate as those diagnosed with a common mental disorder). Among respondents diagnosed with a mental disorder, 34% had consulted health services in the same period. 37 These figures are higher than data reported in the European Study of Epidemiology of Mental Disorders, perhaps because the European Study of Epidemiology of Mental Disorders data referred to formal service use only. [38] [39] [40] Previous studies have demonstrated a substantial gap between levels of immigrants' mental health needs and their use of mental health services. [41] [42] [43] [44] [45] [46] [47] [48] The explanations for this gap have included: age at migration and length of residence, 47 low education leve1, 41 cultural and linguistic barriers to accessing care, 22, 26, 48, 49 unfamiliarity with local mental health services, 42 poor state of health, 50 high number of somatic symptoms, 51 the dismissive attitudes of doctors, and the doctors' reliance on pharmaceutical interventions in contrast to the immigrants' faith in the curative powers of nonmedical interventions, such as divine will and traditional folk medicine. 43 The results of our study do not indicate an underuse of mental health services among immigrants, compared with veteran Israelis. A possible explanation for this parity may be either the similar rates for common mental disorders, indicating the same level of health care need in both populations, or the absence of barriers to access for Israel's immigrants. There are several reasons why Israel's immigrants may find mental health care more accessible than immigrants elsewhere. All immigrants in Israel receive special social and financial support from the government, including full medical insurance coverage, which removes the financial barrier to service use. Former Soviet Union immigrants have less negative and stigmatizing attitudes to, and a higher level of trust in, Israeli psychiatric services, in contrast to the negative image of Soviet psychiatry, which has often been misused and manipulated by the regime for political reasons. 52 Finally, the language barrier is almost insignificant as many immigrant mental Mood stabilizers 0.9 (7) 7.1 (0. health care providers have entered the health services profession in Israel and it is usually not difficult to find Russianspeaking mental health personnel.
Psychotropic Drug Use
In most countries the proportion of psychiatric medications in the gross domestic health product is rapidly increasing. 53 Nonetheless, epidemiologic studies have indicated that patients with common mental disorders are frequently mistreated (that is, treated with inappropriate drugs) or undertreated (treated with appropriate drugs in insufficient doses). [54] [55] [56] For instance, according to the Canadian Community Health Survey: Mental Health and Well-Being, 66% of respondents diagnosed with bipolar disorder did not take a mood stabilizer or ADs, and 22% took ADs without a mood stabilizer. 46 The INHS found a 6.9% rate of psychotropic drug use in the general population and a 19.6% rate in respondents with any 12-month psychiatric disorder. 57 In our study, we found that, compared with their Israeli counterparts, immigrants have a higher 12-month prevalence rate for use of any class of psychotropic drugs. This result reflects a higher use of anxiolytic, mood stabilizer, and hypnotic drugs, but not of ADs and antipsychotics. The most interesting finding is that this pattern of drug use was found only among respondents who failed to meet the DSM-IV criteria for a specific mental disorder. Thus the discrepancies in drug use we found between immigrants and veteran Israelis cannot be attributed to differences in the prevalence rates for common mental disorders and health services use.
The higher use of psychotropic drugs by immigrants may be an indirect indicator of a higher level of psychological distress symptoms, such as anxiety, depression, and sleep disorders. It is also possible that it is this drug use that does not allow the distressing symptoms to reach the threshold required for a diagnosis of a specific mental disorder based on DSM-IV criteria. Another explanation for this finding could be diagnostic bias, as a result of the tendency of some immigrants to underreport distressing symptoms. 58 However, this explanation seems most unlikely because in a previous study, also based on the INHS, we found that immigrants from different countries to Israel between 1989 and 2004 were twice as likely as Israelis to report both mild and severe psychological distress (as measured by the General Health Questionnaire-12). 59 Hence we suggest that treating distressing symptoms with psychotropic drugs may be keeping psychiatric morbidity in the immigrant population at the levels similar to those found in the host population.
Numerous studies have reported higher levels of psychological distress associated with immigration. [60] [61] [62] Research also suggests that there are certain risk periods for psychological distress and psychiatric morbidity among immigrants. For instance, a study of recent immigrants from the former Soviet Union to Israel 17 demonstrated a 2-phase temporal pattern in the development of psychological distress. In the escalation phase, distress levels gradually rose to a peak in the 27th month after arrival, and in the reduction phase, distress levels fell to normal levels by the 44th month after arrival. Our findings suggest that this emotional distress may return in the later stages of adjustment to immigration, as our respondents had been in the country for an average of 9 years. The findings also imply that the above-described temporal pattern of immigration distress may be subject to variation and that in some cases distress may persist for many years. 63 The 12-month use of psychotropic drugs found by our study was twice as high for women as for men, in accord with what previous studies have consistently reported¯that women have higher rates of psychological distress than men. [34] [35] [36] The sex differences in psychotropic drug use found in our study lend further, if indirect, support to the argument that increased drug use by immigrants may be caused by higher levels of psychological distress.
Limitations and Strengths
The first obvious limitation of this study is that we did not divide the Israeli sample into native-born and pre-1989 immigrant subsamples, and that we combined all post-1989 immigrants into a single category, wherever they came from. We did this to support sufficient statistical power of our analyses. However, the heterogeneity of the Israeli population, made up of the native-born plus immigrants from 70 countries, could be exploited to check the direction of the association between immigration and health indicators among a range of ethnic groups. Further research is needed to examine the ethnic factors that may be affecting the variables we studied. For now, extrapolating our findings to immigrant populations in other countries should be done with caution.
Another limitation of our study is that we did not analyze data on the nonmedication treatment of psychiatric disorders. Most of our respondents (75% to 80%) who had been diagnosed with a common mental disorder reported not receiving psychotropic treatment, suggest that some of them may have been treated with psychotherapy or alternative and complementary therapies. Assuming that cognitive-behavioural therapy for common mental disorders is as popular among patients and physicians as pharmacotherapy, 64, 65 it is possible that the extent of undertreatment is actually lower than we report. A further drawback is that we analyzed any drug taken at any dosage during the previous year without measuring the duration of treatment, which means that we cannot evaluate the appropriateness of the treatment received for each psychiatric disorder. We plan further analyses to fill these gaps.
Our study also enjoys considerable methodological strengths: it is based on rigorous sampling procedures and a reliably representative sample of the country's population; a relatively high response rate was achieved; the interviews were conducted in the respondents' mother tongue (Hebrew, Arabic, or Russian), which increased the likelihood that the respondents understood the questions; the interviews were conducted with the assistance of computer programs, which increased data quality by drastically reducing between-interviewer variation; and the use of a standard uniform instrument as part of the World Health Organization's World Mental Health Survey creates an opportunity for cross-country comparisons.
Implications
Our findings have important implications for mental health services. They show that, although the mental health care needs of immigrants may be no higher than those of Israelis, the former use more psychotropic drugs. Under such circumstances, the role of family physicians as first gatekeeper assumes increased importance. These doctors, if properly trained in culturally sensitive care provision, may be able to detect and treat immigrants' psychological symptoms with psychotropic drugs at an early stage, thus preventing the development of full-blown psychiatric disorders. 
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Résumé : Les troubles anxieux et de l'humeur, l'utilisation des services et les psychotropes dans une population d'immigrants : les résultats de l'Enquête nationale sur la santé en Israël
Objectif : À l'aide de l'Enquête nationale sur la santé en Israël (ENSI), nous avons comparé la prévalence de 12 mois des troubles mentaux, l'utilisation des services et les psychotropes des immigrants avec ceux de la population générale.
Méthodes : Un échantillon représentatif de résidents non institutionnalisés, âgés de 21 ans et plus, a été tiré du registre national de la population. Les troubles du Manuel diagnostique et statistique des troubles mentaux, 4 e édition (DSM-IV) ont été évalués au moyen d'une version révisée de l'entrevue diagnostique composite internationale. Les répondants devaient déclarer toute utilisation des services de santé et des psychotropes au cours des 12 derniers mois.
Résultats : Durant les 12 mois précédant l'ENSI, les immigrants et les Israéliens de longue date étaient également susceptibles de souffrir d'un trouble mental commun (OR 0,9; 95 % IC 0,7 à 1,1) et d'utiliser les services de santé (OR 0,9; 95 % IC 0,7 à 1,2). Cependant, parmi les répondants qui ne satisfaisaient pas aux critères du DSM-IV d'un trouble mental spécifique, les immigrants ont déclaré notablement plus d'utilisation des psychotropes que les Israéliens, en particulier plus d'anxiolytiques, de stabilisateurs de l'humeur et d'hypnotiques.
Conclusion :
Les résultats suggèrent que les troubles mentaux communs et l'utilisation des services de santé chez les immigrants ne sont pas plus élevés que ceux de leurs homologues Israéliens. L'utilisation plus marquée de psychotropes par les immigrants peut être un indicateur indirect d'un niveau plus élevé de symptômes de détresse psychologique, comme l'anxiété, la dépression, et les troubles du sommeil.
